Correlation Between Viatris and Crinetics Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viatris and Crinetics Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viatris and Crinetics Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viatris and Crinetics Pharmaceuticals, you can compare the effects of market volatilities on Viatris and Crinetics Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viatris with a short position of Crinetics Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viatris and Crinetics Pharmaceuticals.
Diversification Opportunities for Viatris and Crinetics Pharmaceuticals
0.52 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Viatris and Crinetics is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Viatris and Crinetics Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Crinetics Pharmaceuticals and Viatris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viatris are associated (or correlated) with Crinetics Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Crinetics Pharmaceuticals has no effect on the direction of Viatris i.e., Viatris and Crinetics Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viatris and Crinetics Pharmaceuticals
Given the investment horizon of 90 days Viatris is expected to generate 5.2 times less return on investment than Crinetics Pharmaceuticals. But when comparing it to its historical volatility, Viatris is 2.42 times less risky than Crinetics Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Crinetics Pharmaceuticals is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 1,670 in Crinetics Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of 4,047 from holding Crinetics Pharmaceuticals or generate 242.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Viatris vs. Crinetics Pharmaceuticals
Performance |
| Timeline |
| Viatris |
| Crinetics Pharmaceuticals |
Viatris and Crinetics Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viatris and Crinetics Pharmaceuticals
The main advantage of trading using opposite Viatris and Crinetics Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viatris position performs unexpectedly, Crinetics Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Crinetics Pharmaceuticals will offset losses from the drop in Crinetics Pharmaceuticals' long position.| Viatris vs. Catalent | Viatris vs. Bausch Health Companies | Viatris vs. Tilray Inc | Viatris vs. Takeda Pharmaceutical Co |
| Crinetics Pharmaceuticals vs. Viridian Therapeutics | Crinetics Pharmaceuticals vs. Cytokinetics | Crinetics Pharmaceuticals vs. Structure Therapeutics American | Crinetics Pharmaceuticals vs. Passage Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Stocks Directory Find actively traded stocks across global markets |